Literature DB >> 9247243

The improved outlook for biliary atresia with corticosteroid therapy.

T Muraji1, Y Higashimoto.   

Abstract

Controversy exists regarding the efficacy of corticosteroids on bile flow after Kasai portoenterostomy in biliary atresia (BA). Fourteen patients who had BA and underwent Kasai portojejunostomy between November 1990 and March 1996 were subject of this study. Corticosteroid therapy ("blast" type) was used for inadequate bile drainage. Corticosteroid support was unnecessary in one patient with good bile drainage, and corticosteroids were aggressively used in the remaining 13 patients. Two patients who had no response to an initial blast subsequently responded and now are doing well. The remaining 11 patients responded to corticosteroids with varying degrees. Three had a limited response, and two ultimately underwent liver transplantation. There was one death caused by subdural hematoma. Three had an excellent initial response. However, one subsequently deteriorated because of intractable cholangitis, requiring liver transplantation. Ten survivors with native liver are anicteric with satisfactory growth and quality of life. Aggressive corticosteroid therapy is an important part of the management after Kasai portoenterostomy. The initial response to steroids does not necessarily reflect the final outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247243     DOI: 10.1016/s0022-3468(97)90408-5

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  17 in total

1.  Corticosteroid treatment in biliary atresia: Tonic or toast?

Authors:  Ronald J Sokol
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

2.  The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival.

Authors:  Riccardo Superina; John C Magee; Mary L Brandt; Patrick J Healey; Greg Tiao; Fred Ryckman; Frederick M Karrer; Kishore Iyer; Annie Fecteau; Karen West; R Cartland Burns; Alan Flake; Hanmin Lee; Jeff A Lowell; Pat Dillon; Paul Colombani; Richard Ricketts; Yun Li; Jeffrey Moore; Kasper S Wang
Journal:  Ann Surg       Date:  2011-10       Impact factor: 12.969

Review 3.  Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?

Authors:  Mark Davenport
Journal:  Pediatr Surg Int       Date:  2017-09-22       Impact factor: 1.827

Review 4.  Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? Systematic review and meta-analysis.

Authors:  Ahmed Sarkhy; Richard A Schreiber; Ruth A Milner; Collin C Barker
Journal:  Can J Gastroenterol       Date:  2011-08       Impact factor: 3.522

Review 5.  Recent advances in the pathogenesis and management of biliary atresia.

Authors:  Jessica A Zagory; Marie V Nguyen; Kasper S Wang
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

6.  Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial.

Authors:  Jorge A Bezerra; Cathie Spino; John C Magee; Benjamin L Shneider; Philip Rosenthal; Kasper S Wang; Jessi Erlichman; Barbara Haber; Paula M Hertel; Saul J Karpen; Nanda Kerkar; Kathleen M Loomes; Jean P Molleston; Karen F Murray; Rene Romero; Kathleen B Schwarz; Ross Shepherd; Frederick J Suchy; Yumirle P Turmelle; Peter F Whitington; Jeffrey Moore; Averell H Sherker; Patricia R Robuck; Ronald J Sokol
Journal:  JAMA       Date:  2014-05-07       Impact factor: 56.272

7.  Steroid use after the Kasai procedure for biliary atresia.

Authors:  Oliver B Lao; Cindy Larison; Michelle Garrison; Patrick J Healey; Adam B Goldin
Journal:  Am J Surg       Date:  2010-05       Impact factor: 2.565

8.  Choleretic actions of insulin-like growth factor-I, prednisolone, and ursodeoxycholic acid in rats.

Authors:  Miyuki Mabuchi; Ikuo Kawamura; Mariko Fushimi; Shigeru Takeshita; Shoji Takakura; Jiro Hirosumi; Seitaro Mutoh
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

9.  Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia.

Authors:  Masaki Nio; Toshihiro Muraji
Journal:  Pediatr Surg Int       Date:  2013-11       Impact factor: 1.827

10.  Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation.

Authors:  Cara L Mack; Rebecca M Tucker; Ronald J Sokol; Frederick M Karrer; Brian L Kotzin; Peter F Whitington; Stephen D Miller
Journal:  Pediatr Res       Date:  2004-05-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.